These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7493689)

  • 1. Review of the endometrial safety during intravaginal treatment with estriol.
    Vooijs GP; Geurts TB
    Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):101-6. PubMed ID: 7493689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
    Melis GB; Cagnacci A; Bruni V; Falsetti L; Jasonni VM; Nappi C; Polatti F; Volpe A
    Maturitas; 1996 May; 24(1-2):83-90. PubMed ID: 8794438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.
    Foidart JM; Vervliet J; Buytaert P
    Maturitas; 1991 Jun; 13(2):99-107. PubMed ID: 1921739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses.
    Bottiglione F; Volpe A; Esposito G; Aloysio DD
    Maturitas; 1995 Nov; 22(3):227-32. PubMed ID: 8746880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of oral estriol on the endometrium in postmenopausal women.
    Granberg S; Eurenius K; Lindgren R; Wilhelmsson L
    Maturitas; 2002 Jun; 42(2):149-56. PubMed ID: 12065174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of estriol replacement therapy for climacteric women.
    Yang TS; Tsan SH; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review.
    Rueda C; Osorio AM; Avellaneda AC; Pinzón CE; Restrepo OI
    Climacteric; 2017 Aug; 20(4):321-330. PubMed ID: 28622049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
    Fink BJ
    Maturitas; 1984 Apr; 5(4):277-80. PubMed ID: 6738374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
    Weiderpass E; Baron JA; Adami HO; Magnusson C; Lindgren A; Bergström R; Correia N; Persson I
    Lancet; 1999 May; 353(9167):1824-8. PubMed ID: 10359406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial effect of oral estriol treatment in postmenopausal women.
    Englund DE; Johansson ED
    Acta Obstet Gynecol Scand; 1980; 59(5):449-51. PubMed ID: 7446012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
    Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
    Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
    Capobianco G; Wenger JM; Meloni GB; Dessole M; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2014 Mar; 289(3):601-8. PubMed ID: 24057079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
    Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound imaging of the lower urinary tract in post-menopausal women with urinary stress or combined type of incontinence before and after intravaginal administration of estriol].
    Martan A; Masata J; Halaska M; Voigt R
    Ceska Gynekol; 1999 Jan; 64(1):6-9. PubMed ID: 10377583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women.
    Gerbaldo D; Ferraiolo A; Croce S; Truini M; Capitanio GL
    Maturitas; 1991 Oct; 13(4):269-74. PubMed ID: 1775080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.